thymidine has been researched along with tacrine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nicosia, V; Zambenedetti, P; Zatta, P | 1 |
| Berson, A; Demeilliers, C; Descatoire, V; Feldmann, G; Fromenty, B; Haouzi, D; Mansouri, A; Pessayre, D; Sutton, A; Vadrot, N | 1 |
2 other study(ies) available for thymidine and tacrine
| Article | Year |
|---|---|
Evaluation of MAO activities on murine neuroblastoma cells upon acute or chronic treatment with aluminium (III) or tacrine.
Topics: Aluminum; Animals; Carbon Radioisotopes; Enzyme Activation; Leucine; Mice; Monoamine Oxidase; Neuroblastoma; Radiochemistry; Tacrine; Thymidine; Time Factors; Tritium; Tumor Cells, Cultured | 1998 |
Tacrine inhibits topoisomerases and DNA synthesis to cause mitochondrial DNA depletion and apoptosis in mouse liver.
Topics: Animals; Apoptosis; DNA; DNA Fragmentation; DNA Polymerase gamma; DNA Replication; DNA-Directed DNA Polymerase; DNA, Circular; DNA, Mitochondrial; DNA, Superhelical; Enzyme Inhibitors; Liver; Male; Membrane Potentials; Mice; Mice, Inbred Strains; Necrosis; Oxidative Stress; Oxygen Consumption; Permeability; Tacrine; Thymidine; Time Factors; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 2003 |